| 证券代码 | ALXN.O |
| 证券名称 | 亚力兄制药 |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 1996-02-29 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Alexion Pharmaceuticals, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 100 College Street, New Haven, Connecticut, USA |
| 成立日期 | 1992 |
| 董事会主席 | David R. Brennan |
| 公司属地 | United States 美国 |
| 公司网址 | www.alexion.com |
| 电话 | +1 (475) 230-2596 |
| 传真 | +1 (203) 271-8198 |
| 公司简介 | Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. Alexion has been named to the Forbes list of the World's Most Innovative Companies seven years in a row and is headquartered in Boston, Massachusetts' Innovation District. |